Integrated management of multidrug-resistant tuberculosis, HIV, and hepatitis B co-infection in Ghana: a case report

• by Stanley Yaidoo, Judith Maame Tanoa Yelbert, Rodger MacScott-Lutterodt, Elizabeth Nkumah Obeng, Stephannie Kafui Amenya

• June 15, 2026

Side Effects: Four Studies Worth Passing On

Kissing celiacs, Ozempic genes, Viagra for the brain, and a UTI test that actually works. This week's evidence is weird, useful, and worth your time.

• by Kerri Miller

• April 9, 2026

• 6 min

Dalbavancin Exposure Linked to Higher Success in Bacteremia

Higher day 22 concentrations were associated with improved outcomes, though findings remain exploratory

• by Kathryn Wighton

• May 6, 2026

• 4 min

Immune imbalance markers: key factors in early recognition of multidrug-resistant bacterial infections in non-immunocompromised VAP patients

• by Mingying Tang, Qiyong Meng, Zhimin Huang, Yongjun Qing, Weijian Lei

• June 4, 2026